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The effect of dietary fat intake on hepatic
gene expression in LG/J AND SM/J mice
Charlyn G Partridge1,4*, Gloria L Fawcett1,2, Bing Wang1, Clay F Semenkovich3 and James M Cheverud1,5

Abstract
Background: The liver plays a major role in regulating metabolic homeostasis and is vital for nutrient metabolism.
Identifying the genetic factors regulating these processes could lead to a greater understanding of how liver
function responds to a high-fat diet and how that response may influence susceptibilities to obesity and metabolic
syndrome. In this study we examine differences in hepatic gene expression between the LG/J and SM/J inbred
mouse strains and how gene expression in these strains is affected by high-fat diet. LG/J and SM/J are known to
differ in their responses to a high-fat diet for a variety of obesity- and diabetes-related traits, with the SM/J strain
exhibiting a stronger phenotypic response to diet.
Results: Dietary intake had a significant effect on gene expression in both inbred lines. Genes up-regulated by a
high-fat diet were involved in biological processes such as lipid and carbohydrate metabolism; protein and amino
acid metabolic processes were down regulated on a high-fat diet. A total of 259 unique transcripts exhibited a
significant diet-by-strain interaction. These genes tended to be associated with immune function. In addition,
genes involved in biochemical processes related to non-alcoholic fatty liver disease (NAFLD) manifested different
responses to diet between the two strains. For most of these genes, SM/J had a stronger response to the
high-fat diet than LG/J.
Conclusions: These data show that dietary fat impacts gene expression levels in SM/J relative to LG/J, with SM/J
exhibiting a stronger response. This supports previous data showing that SM/J has a stronger phenotypic response
to high-fat diet. Based upon these findings, we suggest that SM/J and its cross with the LG/J strain provide a good
model for examining non-alcoholic fatty liver disease and its role in metabolic syndrome.
Keywords: Liver, Dietary fat, Non-alcoholic fatty liver disease, NAFLD, Gene expression, Microarray, SM/J, LG/J

Background
The relationship between dietary intake and metabolic
syndrome is complex, with a number of genes, genetic
interactions, and gene by environment interactions having significant effects on disease susceptibility and severity. Obesity-related metabolic disorders can occur when
dietary energy intake chronically exceeds expenditure
leading to a variety of conditions that include increased
blood pressure, insulin resistance, and serum cholesterol
levels [1]. Obesity per se is significantly influenced by
both environmental factors, such as diet and exercise,
and genetic factors, with heritability estimates ranging
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from 40% to 75% [2,3]. More critically, there is genetic
variation among individuals in their responses to an obesogenic diet, with some being more likely to develop aspects of metabolic syndrome than others [4,5].
While metabolism involves a number of different organs, the liver is one of the key organs regulating nutrient homeostasis. Because of its direct involvement in
dietary nutrient metabolism, the liver’s functional association to dietary obesity and metabolic syndrome is of
keen interest. Previous work has shown that increased
levels of dietary fat intake are associated with increased
fat deposition in the liver and can lead to non-alcoholic
fatty liver disease (NAFLD) [6-8]. This increase in hepatic fat is associated with a higher risk of obesity [9], insulin resistance [10-12], and type 2 diabetes mellitus
[13,14]. As with obesity and metabolic syndrome, it has
been suggested that susceptibility to NAFLD also has a

© 2014 Partridge et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.

Partridge et al. BMC Genomics 2014, 15:99
http://www.biomedcentral.com/1471-2164/15/99

strong genetic basis [15-19] with relatively high heritability values after controlling for age, sex, race, and body
mass index [17]. Because of the strong association between hepatic fat accumulation and metabolic syndrome
disorders, understanding how genetic factors influence
the way in which the liver responds to increased dietary
fat levels is critical.
Whole-genome expression studies have previously examined the effect of dietary fat intake on hepatic gene
expression. A review of these studies shows that many of
the genes whose expression is affected by dietary fat are
related to lipid metabolism, adipocyte differentiation,
defense against foreign bodies or injury, and stress response, particularly response to oxidative stress [20]. In
a comprehensive study, Shockley et al. [21] examined
hepatic gene expression profiles in relation to dietary fat
and cholesterol for 10 different inbred mouse strains.
Over all 10 strains, only Gene Ontology (GO) terms for
cholesterol biosynthesis and isoprenoid metabolism were
repressed by a high-fat diet in all of the strains. No biological GO terms were induced by a high-fat diet across
all strains, indicating that differences in genetic background have a dominant effect on which genes and
pathways respond to high dietary fat levels. However, the
level of fat in the high-fat diet used by Shockley et al.
[21] was modest (30% calories from fat), the low fat diet
was not matched for other ingredients [22], and the dietary treatment lasted only from 6–10 weeks of age.
This study was designed to evaluate hepatic gene expression profiles for two mouse strains, LG/J and SM/J,
on both a low and a high-fat diet. While the effect of
dietary intake on hepatic gene expression has been assessed in a number of mouse strains, including SM/J
[21], evaluating differences in expression levels between
SM/J and LG/J provides a unique opportunity to examine the genetic factors associated with a number of obesity and metabolic syndrome related traits. LG/J and
SM/J mice have been shown to differ in their response
to a high-fat diet for traits involved in various metabolic
syndrome domains [23,24]. SM/J individuals tend to be
more responsive to the effect of a high-fat diet in relation to body weight, fat depot weight, organ weight,
basal glucose levels, and triglyceride levels [23,24]. In
addition, quantitative trait loci (QTLs) for a number of
these phenotypes, including obesity [25-29], diabetes
[25,30], serum lipid levels [25,31], fatty liver [32] and
multiple domains of metabolic syndrome [33], have been
mapped in populations derived from the intercross of
these two strains. Thus, the goals of this project are twofold. First, we describe general differences in gene expression between these strains, between males and females,
and between animals reared on low- and high-fat diets.
More critically, we identify genes whose response to a
high-fat diet differs between the LG/J and SM/J strains.
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Second, we relate these expression differences to genes located within previously defined QTLs where genetic effects were found to be diet-specific.

Results
Global gene expression

Of the 26,209 gene transcripts that showed significant
expression levels, a total of 4,796 unique genes were differentially expressed among treatments. Of those, 3,880
transcripts were significantly different between SM/J and
LG/J strains (Additional file 1), 1,224 were significantly
different between males and females (Additional file 2),
and 1,676 transcripts were significantly different by diet
(Additional file 3). Three hundred transcripts showed a
strain by diet interaction, 26 showed a significant strain
by sex interaction, and only two showed a significant
diet-by-sex-by-strain interaction, both of which corresponded to the gene Cidea (Table 1).
Strain Effects. Forty-seven percent of the genes (1,840
gene transcripts) that were significantly different by
strain were expressed more strongly in the LG/J strain
and 53% more strongly in SM/J (2,040 gene transcripts)
(Additional file 1). The genes that were significantly
over-expressed within both LG/J and SM/J strains represented similar biological processes, such as lipid metabolism, protein metabolism and carbohydrate metabolic
processes (Additional file 4). There were, however, differences in the biochemical pathways these genes represented (Additional file 4). Biochemical pathways that
contained the largest number of genes over-expressed in
SM/J included several response-to-stimulus pathways,
including the platelet-derived growth factor (PDGF), integrin, and inflammation by chemokine and cytokine
signaling pathways. In addition, a relatively large number
of genes involved in apoptosis were over-expressed in
SM/J. In LG/J, the metabolic-related pathways that were
enriched included the purine metabolism and the cholesterol biosynthesis pathway. Other interesting pathways
over-expressed in LG/J included the endothelin signaling
pathway, the angiogensis pathway, and the insulin/IGF
pathway.
Table 1 Number of differentially expressed genes for
each factor and their interactions
Factor

Number of significant genes

Diet

1676

Sex

1224

Strain

3880

Diet*Sex

26

Diet*Strain

300

Sex*Strain

0

Diet*Sex*Strain

2
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Sex Effects. Of the 1,224 expressed transcripts that
were significantly different between males and females,
46% were higher in males (568 gene transcripts) and
54% were higher in females (656 gene transcripts)
(Additional file 2). As expected, genes that are sexlinked showed significant differences in expression between the sexes. Inactive X specific transcripts (Xist),
located on the X chromosome, displayed the largest differences between males and females. Genes located on

the Y chromosome, such as DEAD box polypeptide 3, Ylinked (Ddx3y), eukaryotic translation initiation factor 2,
subunit 3, structural gene Y-linked (Eif2s3y) and ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome (Uty), were expressed more in males. A number
of cytochrome p-450 genes (Cyp) were also differentially
expressed between the sexes (Additional file 2). Both
males and females exhibited high expression in genes related to biological processes, such as lipid metabolism,

Table 2 Biological processes and biochemical pathways enriched by genes exhibiting a diet by strain interaction
GO annotation term

GO annotation

Mus musculus
genes FEFLIST
(26185)

Number of
genes in
pathway

Number
of genes
expected

Over/
under
represented

P-value

immune system process

GO:0002376

2974

62

20.22

+

1.72×10-16

antigen processing and presentation

GO:0019882

95

10

0.65

+

1.54×10-9

GO:0002504

35

6

0.24

+

1.90×10-7

response to stimulus

GO:0050896

2486

52

16.9

+

1.01×10-13

response to stress

GO:006950

547

13

3.72

+

1.08×10-4

GO:0006968

564

16

3.83

+

1.93×10-6

response to toxin

GO:0009636

121

9

0.82

+

1.92×10-7

signal transduction

GO:0007165

4858

52

33.02

+

3.68×10-4

immune response

GO:0006955

900

16

6.12

+

4.75×10-4

10946

39

74.41

-

1.81×10-8

GO:0008152

9603

93

65.28

+

1.63×10-5

primary metabolic process

GO:0044238

9122

91

62.01

+

6.03×10-6

lipid metabolic process

GO:0006629

1266

24

8.61

+

6.06×10-6

carbohydrate metabolic process

GO:005975

1038

19

7.06

+

9.55×10-5

cellular process

GO:0009987

7133

69

48.49

+

5.51×10-4

endocytosis

GO:0006897

604

14

4.11

+

7.65×10-5

apoptosis

GO:0006915

1035

18

7.04

+

2.73×10-4

developmental process

GO:0032502

3296

38

22.41

+

7.37×10-4

system development

GO:0048731

2222

29

15.1

+

5.23×10-4

transport

GO:0006810

3009

36

20.45

+

5.33×10-4

Plasminogen activation cascade

18

3

0.12

+

2.74×10-4

p53 pathway

127

5

0.86

+

1.89×10-3

Angiogenesis

193

6

1.31

+

2.22×10-3

Blood coagulation

55

3

0.37

+

6.52×10-3

Integrin signalling pathway

185

5

1.26

+

9.06×10-3

Androgen/estrogene/progesterone biosynthesis

28

2

0.19

+

1.59×10-2

Ornithine degradation

3

1

0.02

+

2.02×10-2

FAS signaling pathway

38

2

0.26

+

2.80×10-2

Methylmalonyl pathway

5

1

0.03

+

3.34×10-2

Xanthine and guanine salvage pathway

6

1

0.04

+

4.00×10-2

p53 pathway feedback loops 2

51

2

0.35

+

4.77×10-2

Biological Process

antigen processing and presentation of
peptide or polysaccharide antigen via
MHC class II

cellular defense response

Unclassified
metabolic process

Biochemical Pathway
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carbohydrate metabolism, response to toxin, apoptosis
and the generation of precursor metabolites and energy
(Additional file 5), but the specific genes involved differed between males and females. On the other hand,
the biochemical pathways represented by genes overexpressed in females differed substantially from those
up-regulated in males. Pathways with genes expressed
significantly higher in females were typically associated
with amino acid biosynthesis, whereas pathways associated with increased expression in males were involved in
a number of signaling pathways, including the heterotrimeric G-protein signaling pathway-Gi alpha and Gs
alpha mediated pathway, the endothelial signaling pathway, and the cortocotropin releasing factor receptor signaling pathway (Additional file 5).
Response to Diet. For genes that were expressed differently on high and low-fat diets, 46% were higher in
high-fat fed individuals (775 genes transcripts), while
54% (901 gene transcripts) were higher in low-fat fed individuals (Additional file 3). GO terms that were
enriched for genes that showed significantly higher expression in high-fat fed individuals were involved in lipid
and carbohydrate metabolism. Processes enriched in
low-fat fed individuals included those involved in protein
and amino acid metabolic processes (Additional file 6).
Interesting biochemical pathways that were enriched by
genes showing higher expression with high-fat diet are
involved in stress response, such the p53 pathway, integrin signaling pathway, ubiquitin promeasome pathway,
and the inflammation-mediated by chemokine and cytokine signaling pathways. Those enriched with genes that
exhibited higher expression on a low-fat diet included
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blood coagulation, EGF receptor signaling, cholesterol
biosynthesis, and a number of amino acid biosynthesis
pathways (Additional file 6).
Diet-by-Strain Interactions. There were 259 genes (300
gene transcripts) whose expression exhibited a significant
diet-by-strain interaction, i.e. diet affected expression differently in the two strains (Additional file 7). Gene expression was much more responsive to the high-fat diet in
SM/J than in LG/J, with 95% of the diet related expression
changes occurring in SM/J. GO terms enriched for genes
exhibiting a diet-by-strain interaction included those involved in immune function, lipid and carbohydrate metabolic processes, and apoptosis (Table 2). The biochemical
pathways that were significantly enriched included the
plasminogen activating pathway, p53 pathway, angiogenesis, the integrin signaling pathway, and the blood coagulation pathway (Table 2).
In order to evaluate gene clusters that responded similarly for genes exhibiting a diet-by-strain interaction, a
K-means clustering analysis was preformed and produced 2 stable gene clusters. Cluster 1 is composed of
genes involved in response to stimulus pathways, such
as the p53 pathway, integrin signaling pathway, and the
TGF signaling pathway (Additional file 8). Cluster two
was comprised of pathways related to multiple salvage
pathways, the plaminogen activating cascade, and blood
coagulation (Additonal file 8). Hierarchical biclustering
of the data also show that high-fat fed SM/J individuals
clustered separately from all other groups for these
genes (Figure 1).
Within Strain Effects. Analyzing SM/J and LG/J separately for the effects of diet and sex on gene expression

Figure 1 Heat map of genes exhibiting a diet by strain interaction. Hierarchical cluster analysis was performed producing two clusters, with
the high-fat fed SM/J group clustering separately from all other groups. HF-LG: High-fat LG/J; HF-SM: High-fat SM/J; LF-LG: Low-fat LG/J; LF-SM:
Low-fat SM/J.
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produced very different results. When SM/J was analyzed separately, diet had the strongest effect on gene expression with 2,137 gene transcripts being differentially
expressed. Of these, 1,200 transcripts were up-regulated
and 937 down-regulated on the high-fat diet (Additional
file 9). Only 25 gene transcripts showed differential expression in relation to diet in the LG/J strain, 15 with increased expression and 10 with decreased expression on
a high-fat diet (Additional file 9).
The major factor responsible for variation in LG/J gene
expression was sex, with 637 transcripts differentially
expressed between males and females. Of the 637 transcripts, 396 were higher in females and 241 were higher in
males. This is in sharp contrast to the sex effects observed
in SM/J, where only 190 transcripts showed differential
expression (Additional file 10).
Candidate Genes within QTLs

Studies of these strains have previously mapped QTLs affecting obesity, diabetes-related traits, and serum lipid
levels in the LG,SM Advanced Intercross Lines (AIL). We
correlated the list of genes in these QTLs with those demonstrating a differential response between strains to a high
fat diet. Of the 259 genes showing different responses in
LG/J and SM/J in relation to the high fat diet, 18 are located within QTLs previously mapped for serum lipid
levels [31], 24 are located within QTLs mapped for obesity
[27], and 20 are located within regions previous associated
with diabetes [30] (Table 3). Chi-square analysis show
QTLs previously identified as associated with serum lipid
levels and obesity were significantly enriched with genes
showing significant diet-by-strain interactions (Obesity:
χ2=5.95, p=0.015; Lipids: χ2=6.91, p=0.008). However,
QTLs associated with diabetes were not enriched
(χ2=1.49; p=0.22). This result indicates that differential
gene expression between strains in response to diet is the
likely source of at least some of the mapped QTL effects.

Discussion
This study has two main goals. The first, to characterize
hepatic gene expression profiles for SM/J and LG/J inbred mouse strains and examine how these profiles were
influenced by diet and sex. The second goal is to examine how expression profiles differ between these two
strains in relation to diet, and to characterize potential
candidate genes located within previously mapped QTLs
that are associated with traits from metabolic syndrome
domains. As expected, our results show that diet, sex,
and strain all have significant impacts on gene expression, with many genes showing strain-specific dietary responses for gene expression.
Overall, the impact of the high-fat diet on gene expression appears to be similar to that found in other expression studies [20]. There are many more effects than
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noted in Shockley et al. [21] perhaps because of the
higher amount of fat in the diet utilized here (42% vs
30%) and the prolongation of the dietary treatment, from
6–10 weeks compared to 3–20 weeks in our study. A
number of defense and stress response pathways were
enriched by genes over-expressed in high-fat fed mice,
including the p53, the inflammation mediated by chemokine and cytokine, and the ubiquitin signaling pathways,
which regulate cellular damage response and influence
inflammatory response. Enrichment of these pathways
supports previous work suggesting that a high-fat diet
can lead to cellular oxidative stress and increased inflammation within the liver, potentially resulting in nonalcoholic steatohepatitis (NASH), liver fibrosis, and
further exacerbating insulin resistance [34-38].
SM/J and LG/J differ in their phenotypic response to a
high-fat diet, with SM/J being more responsive than
LG/J for many obesity, diabetes-related, and serum lipid
level traits [23,24]. While these phenotypic differences
between these strains have previously been observed, the
stark differences in how diet impacts gene expression is
somewhat surprising. A total of 259 unique genes displayed significant diet-by-strain interactions. In 95% of
these cases, SM/J mice displayed a greater change in expression in relation to diet than LG/J mice. Hierarchical
cluster analysis of these genes grouped high-fat fed SM/J
separately from all other groups (Figure 1), again demonstrating that SM/J is more responsive to dietary fat intake than LG/J. This suggests that genetic background
plays a significant role in influencing how genes respond
to high-fat diet.
Similar to these results, Shockey et al’s. [21] assessment of how high fat diet affected gene expression
showed that only a few biochemical pathways were commonly affected across the strains that were analyzed.
This suggests that there is little consistency between
strains in what is up- or down-regulated on a high fat
diet. This is an important consideration because it
means that genetic background plays a significant role in
how diet impacts gene expression in this system. Thus,
one cannot characterize a general murine response to a
high fat diet for hepatic expression using any specific
strain, such as C57BL/6J. While this may seem like an
obstacle for murine studies of hepatic gene expression, it
also provides a great opportunity to examine how genetic background influences these effects.
The biological processes that are most enriched with
genes showing diet-by-strain interactions were mainly
related to immune system processes, specifically antigen
processing and presentation. Most of the differences
were driven by the effects of the high-fat diet in SM/J
mice. Associated with these are a number of transcripts
involving major histocompatibilty complexes (MHC) I
and II (Hfe, H2-D1, H2-D4, H2-Ea, H2-Ab1, H2-DMa)
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Table 3 Genes transcripts with a significant diet by strain interaction for lipid, obesity, and diabetes QTLs
QTL

Probe ID

Gene ID

Chromosome

Start

Stop

Strand

Dserum1b

ILMN_2717387

Fbxo36

1

84836416

84897062

+

Dserum1b

ILMN_2502317

Ugt1a10

1

89951963

90115579

+

Dserum1b

ILMN_2754718

Ugt1a9

1

89967375

90115572

+

Dserum1c

ILMN_2954575

Arhgap30

1

173319085

173340429

+

Dserum3a

ILMN_2529128

LOC329702

3

89169322

89178368

+

Dserum3a

ILMN_2883392

S100a11

3

93324410

93330209

+

Dserum3a

ILMN_1213457

Snx27

3

94301466

94386638

-

Dserum3a

ILMN_2837802

BC028528

3

95687877

95695928

-

Dserum3a

ILMN_2656422

BC028528

3

95687877

95695928

-

Dserum4a

ILMN_2674367

Agrn

4

155539399

155560010

-

Dserum5a

ILMN_2690061

Hnrpdl

5

100462596

100468683

-

Dserum8a

ILMN_2719473

Asf1b

8

86479406

86494096

+

Dserum10a

ILMN_3100812

Gpx4

10

79509911

79519184

+

Dserum10a

ILMN_2684855

Gpx4

10

79509911

79519184

+

Dserum17a

ILMN_2729447

9030612M13Rik

17

32910210

32924492

-

Dserum17a

ILMN_1236993

March2

17

33825041

33855598

-

Dserum17a

ILMN_1226525

H2-Ab1

17

34400185

34406355

+

Dserum17a

ILMN_2631423

H2-Ab1

17

34400185

34406355

+

Dserum17a

ILMN_2913716

H2-Ab1

17

3440185

34406355

+

Dserum17a

ILMN_1239102

H2-Eb1

17

34442843

34453144

+

Dserum17a

ILMN_2741935

H2-Ea

17

34479878

34481588

-

Dserum17a

ILMN_2599858

Pbx2

17

34729416

34734286

+

Dserum18a

ILMN_1226868

Mapk4

18

74088140

74225013

-

Dserum19a

ILMN_2677859

Insl6

19

29395844

29399808

-

Dserum19a

ILMN_2738893

Ermp1

19

29682704

29722905

-

Lipid Serum QTLs

Obesity QTLs
Dob2a

ILMN_1220441

Camk1d

2

5214503

5635561

-

Dob3a

ILMN_1219717

Sort1

3

108087009

108164429

+

Dob4a

ILMN_247997

2310040A07Rik/Enho

4

41585177

41587357

-

Dob6a

ILMN_2656021

Osbpl3

6

50243329

50406200

-

Dob6a

ILMN_2974064

Osbpl3

6

50243329

50406200

Dob6e

ILMN_1221060

Pparg

6

115372091

115440419

+

Dob6e

ILMN_1216056

2510049J12Rik

6

115533562

115542594

-

Dob6e

ILMN_2956092

Rassf4

6

116583026

116623809

-

Dob6e

ILMN_2686244

Rassf4

6

116583026

116623809

-

Dob6e

ILMN_2672698

Rassf4

6

116583026

116623809

-

Dob8a

ILMN_2912598

Ap3m2

8

23897827

23916099

-

Dob8c

ILMN_2719473

Asf1b

8

86479406

86494096

+

Dob10b

ILMN_1215807

Glipr1

10

111422511

111439687

-

Doc10c

ILMN_3162796

Cnot2

10

115922222

116018557

-

Doc10c

ILMN_2878071

Lyz

10

116724853

116729924

-

Dob13a

ILMN_2865016

Cd83

13

43880572

43898501

+

Dob14a

ILMN_2627022

Itih4

14

31699662

31715167

+

Dob14a

ILMN_1231336

Itih3

14

31721762

31736731

-

Dob17b

ILMN_1236993

March2

17

33825041

33855598

-
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Table 3 Genes transcripts with a significant diet by strain interaction for lipid, obesity, and diabetes QTLs (Continued)
Dob17b

ILMN_1226525

H2-Ab1

17

34400185

34406355

+

Dob17b

ILMN_2631423

H2-Ab1

17

34400185

34406355

+

Dob17b

ILMN_2913716

H2-Ab1

17

34400185

34406355

+

Dob17b

ILMN_1239102

H2-Eb1

17

34442843

34453144

+

Dob17b

ILMN_2741935

H2-Ea

17

34479878

34481588

-

Dob17b

ILMN_2599858

Pbx2

17

34729416

34734286

+

Dob17b

ILMN_2665266

H2-T10

17

36254035

36258389

-

Dob17b

ILMN_1230878

H2-T10

17

36254035

36258389

-

Dob17b

ILMN_2783997

Trim10

17

37006537

37014750

+

Dob17b

ILMN_2426853

Ubd

17

37330873

37332782

+

Dob17b

ILMN_2964185

H2-M2

17

37617796

37620474

-

Dob17b

ILMN_2742311

Cyp39a1

17

43804474

4388794

+

Dob19a

ILMN_1230587

Lpxn

19

12873133

12908301

+

Ddiab3a

ILMN_1222860

381484

3

15848070

15906332

-

Ddiab4a

ILMN_2773215

Epb4.1l4b

4

57004844

57156309

-

Ddiab4a

ILMN_2775064

Epb4.1l4b

4

57004844

57156309

-

Ddiab4b

ILMN_2736168

Ppt1

4

122513485

122536418

+

Ddiab5a

ILMN_2424721

Pdgfa

5

139451968

139473324

-

Ddiab6a

ILMN_2656021

Ospl3

6

50243329

50406200

-

Ddiab6a

ILMN_2974064

Osbpl3

6

50243329

50406200

-

Ddiab5d

ILMN_1221060

Pparg

6

115372091

115440419

+

Ddiab5d

ILMN_1216056

2510049J12Rik

6

115533562

115542594

-

Ddiab7b

ILMN_2658804

Rras

7

52273348

52277016

+

Ddiab7c

ILMN_2707494

Mcee

7

71537531

71557007

+

Ddiab8a

ILMN_2912598

Ap3m2

8

23897827

23916099

-

Diabetes QTLs

Diab8b

ILMN_2767918

Ifi30

8

73286673

73290562

Diab8b

ILMN_1228213

Ifi30

8

73286673

73290562

-

Diab8b

ILMN_2749747

Haus8

8

73772460

73796833

-

Ddiab11a

ILMN_2727503

Igfbp3

11

7106089

7113900

-

Diab11d

ILMN_3147074

Pecam1

11

106515531

106611942

-

Ddiab13a

ILMN_2595395

Slc17a2

13

23898862

23917049

+

Ddiab13a

ILMN_1217058

Slc17a2

13

23898862

23917049

+

Ddiab13c

ILMN_3122081

5133401N09Rik

13

58259015

58266052

+

Ddiab14b

ILMN_2627022

Itih4

14

31699662

31715167

+

Ddiab14b

ILMN_1231336

Itih3

14

31721762

31736731

-

Diab15b

ILMN_2543688

Snord123

15

32170324

32176484

Ddiab16a

ILMN_1222821

Rogdi

16

5008823

5013610

-

Ddiab17a

ILMN_2933463

Plg

17

12571474

12612250

+

Ddiab19a

ILMN_2744398

Ostf1

19

18653818

18706279

-

Transcripts in bold are located just outside the 95% CI for the QTL and were not included in the enrichment analysis.

and killer cell activation (Tyrobp, Pira11). In most cases,
there was a significant increase in the expression of these
genes with a high-fat diet in SM/J and either no change or
a slight decrease in expression in LG/J. This suggests a
heightened immune response in SM/J with a high-fat diet,
compared to LG/J mice. There is substantial evidence

suggesting a strong association between immune response
and metabolic function [39]. In particularly, diets that are
high in fat have been shown to trigger immune response,
particularly through inflammation in a number of different
tissues (including adipose and liver) [40-42]. For example,
MHC-II expression tends to increase when cells are under
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oxidative stress [43,44], and increased expression of
MHC-II associated genes in hepatic cells can be induced
by altering levels of dietary cholesterol [45]. Severe oxidative stress can lead to cellular damage, resulting in further
hepatic inflammation, and potentially the development of
heptatic steatosis and insulin resistance [34-38]. The difference in immune response in relation to diet between
these two strains may, in part, explain why they differ in
their response to dietary treatment. In particular, it provides some information as to why SM/J mice may show
diminished glucose tolerance in comparison to the LG/J
strain [24] on a high fat diet.
Biochemical pathways that were enriched with genes
showing a diet-by-strain interaction included the plasminogen activating pathway, p53 pathway, and angiogenesis (Table 2). As a consequence of increased hepatic
inflammation and hypoxia, which are associated with
immune response, angiogenesis is commonly induced in
order to increase blood flow and provide oxygen and nutrients to damaged areas [46,47]. Interestingly, Liu et al.
[48] found that angiogenesis in a skin wound-healing
model was higher in the MRL strain, which shares 75%
of its DNA identical-by-descent with LG/J, than in other
strains. In our data, we found that diet affected many
genes within this pathway differently and in a strainspecific fashion. Some genes, including angiopotin (Ang)
and mitogen-activated protein kinase 4 (Mapk4), showed
decreased expression in high-fat fed SM/J mice, Rous
sarcoma oncogene (Src) and Mapk4 showed increased
expression in high-fat fed LG/J mice and the remaining
genes in this pathway with a diet-by-strain effect (i.e.,
platelet derived growth factor (Pdgfa), docking protein 2
(Dok2) and leupaxin (Lpxn)) exhibited increased expression in high-fat fed SM/J (Table 4). Still, the actual
phenotypic effect that these gene expression changes
have on the liver is unclear. For example, Ang and Pdgfa,

along with other growth factors, have a strong proangiogenic effect when up-regulated [47]. In our data
gene expression levels for Ang were lower in SM/J animals fed a high-fat diet, while Pdgfa expression levels
significantly increased. Similarly, Lpxn encodes for the
protein leupaxin, a member of the paxillin protein family, which play an important role in focal cell adhesion
organization and signal transduction within the extracellular matrix [49,50]. It also provides a platform for SRC
protein binding [50,51]. In our data set Src showed increased expression on a high-fat diet in LG/J, while Lpxn
only showed increased expression in high-fat fed SM/J
animals. It, therefore, appears that while high-fat diet
does impact the angiogenesis pathway for both LG/J and
SM/J, the genes that are impacted differ between the
two. To clarify these results future studies assessing the
effects of high-fat diet on angiogenesis for these strains
should continue. Future studies would also be interesting considering how closely related LG/J is to MRL and
MRL’s strong healing phenotype.
One of the most interesting aspects of this study is
that QTLs associated with many metabolic syndrome
domains, including obesity, diabetes, cholesterol and triglyceride levels, and fatty liver, have previously been
mapped in LG/J by SM/J crosses using the same high
and low-fat diets as used in this study [25,27,30-33].
Thus, by examining how gene expression profiles differ
between these strains, particularly for genes within these
QTL regions, we can narrow the number of positional
candidate genes influencing individual dietary response.
Of the 259 gene transcripts with a significant diet by
strain interaction, 57 were located within previously
mapped QTLs. There was a significant enrichment of
genes for obesity and serum lipid level QTLs, although,
no such enrichment occurred for diabetes-related QTLs.
Several metabolic syndrome components are associated

Table 4 Genes expressing significant diet-by-strain interactions within enriched biochemical pathways
Biochemical pathways

Genes within pathway

Plasminogen activating cascade

Serpinf2 (↓HFSm), PlgD(↓HFSm), Fga(↓HFSm)

p53 pathway

Igfbp3D (↑HFSm), E2f1 (↑HFSm), Ccng1(↑HFSm), Tnfrsf6(↑HFSm), Cdc2a(↑HFSm)

Angiogenesis

Src(↑HFLg), Ang(↓HFSm), Mapk4L(↑HFLg, ↓HFSm), Dok2FL(↑HFSm), LpxnMS,Ob(↑HFSm), PdgfaD(↑HFSm)

Blood coagulation

Serpinf2(↓HFSm), PlgD(↓HFSm), Fga(↓HFSm)

Integrin signalling pathway

Fn1(↑HFLg, ↓HFSm), Src(↑HFLg), RrasD(↑HFSm), Mapk4L(↑HFLg, ↓HFSm), Arl11FL(↑HFSm)

Androgen/estrogene/progesterone biosynthesis

Hsd3b4(↓HFLg), Hsd3b2(↓HFSm)

Ornithine degradation

Azi2(↓HFSm)

FAS signaling pathway

Capg(↑HFSm), Tnfrsf6(↑HFSm)

Methylmalonyl pathway

MceeMS,P(↑HFSm)

Xanthine and guanine salvage pathway

Hprt1(↑HFSm)

p53 pathway feedback loops 2

E2f1(↑HFSm), Ccng1(↑HFSm)

Arrows indicate wether expression levels were higher or lower in high-fat fed individuals verses low-fat fed individuals. HFSm=High-fat fed SM/J, HFLg=High-fat
fed LG/J. Genes with superscripts are located within and near previously identified QTLs for a number of traits.
D
Diabetes QTL, LLipid QTL, FLFatty Liver QTL, MSMetabolic Syndrome QTL, OObesity QTL.
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with genes within and around these regions including peroxisome proliferator-activated receptor gamma (Pparg),
energy homeostasis (Enho), insulin-like growth factor
binding protein 3 (Igfbp3), palmitoyl-protein thioesterase
1 (Ppt1), and sortilin 1 (Sort1).
Genes associated with lipid metabolism, such as Pparg
and Enho, were differentially expressed between SM/J and
LG/J strains. Pparg is well known as a major factor involved
in dietary obesity and diabetes [52-54] and one of the major
regulators of adipocyte differentiation. This gene is located
within a QTL affecting both obesity- [27] and diabetesrelated traits [30]. Gene expression profiles for Pparg
showed that high-fat diet increased expression of this gene
in both SM/J and LG/J, although this increase was significantly greater in SM/J individuals (Figure 2A). Enho produces adropin, a protein involved in glucose and lipid
homeostasis [55], and is located within a QTL associated
with obesity [56]. Increased levels of adropin in transgenic
mice were found to be associated with improved response
to diet-induced obesity, insulin resistance, and glucose tolerance [54]. In SM/J, the high-fat diet significantly reduces
the expression of Enho, promoting obesity. Expression was
also reduced in high-fat fed LG/J animals, but this decrease
was not as severe as that observed in SM/J (Figure 2B).
Sortilin (Sort1) plays a significant role in the release of
low-density lipoprotein (LDL) cholesterol from the liver to
the blood stream making it a potentially important gene
for NAFLD and is located just outside the 1-LOD drop
support interval of a QTL mapped for obesity [27]. Recently, single nucleotide polymorphisms (SNPs) located in
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an enhancer region of this gene have shown to be associated with an increased risk of myocardial infarction and increased LDL cholesterol levels. In this study, we found that
the overall levels of Sort1 were significantly higher in SM/J
than in LG/J. However, high-fat diet significantly lowered
expression of Sort1 in SM/J, while this effect was not observed for the LG/J strain (Figure 2C). Similarly, total cholesterol levels from blood serum tend to be lower in SM/J
compared to LG/J, but these values respond more to diet in
SM/J, with high-fat diet eliciting a significant increase [24].
Genes that have been shown to impact NAFLD were
also differentially expressed between LG/J and SM/J.
Platelet/endothelial cell adhesion molecule 1 (Pecam1) is
a glycoprotein located near a QTL for fatty liver [32]
and diabetes [30]. Previous work has suggested that
Pecam1 is involved in regulating inflammation and
higher expression of this gene protects the liver from the
effect of high dietary fat and NAFLD [57]. High-fat fed
SM/J displayed significantly higher Pecam1 expression
levels when compared to low-fat fed individuals. The effect of diet on Pecam1 expression was not significant in
LG/J (Figure 2D). This may suggest that the liver in SM/
J mice is under increased stress when fed a high-fat diet
relative to LG/J. Overall, the expression profiles of genes
in QTLs on a high fat diet, support increased obesity,
serum lipid levels, and diabetes associated with the SM/J
alleles.
The only gene transcripts exhibiting a significant 3way diet-by-sex-by-strain interaction were for the cell
death-inducing DNA fragmentation factor-alpha (Cidea)

Figure 2 Least square mean intensity values for genes within or near previously identified QTLs that exhibited a diet by strain
interaction. (A) Peroxisome proliferator-activated receptor gamma (Pparg); (B) Energy homeostasis (Enho); (C) Sortilin (Sort1); (D) Platelet/endothelial
cell adhesion molecule 1 (Pecam1). Abbrev: LF-SM: Low-fat SM/J; HF-SM: High-fat SM/J; LF-LG: Low-fat LG/J; HF-LG: High-fat LG/J. Graphs based on LS
mean of raw intensity data. Error bars represent standard error of the mean.
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gene. While this gene is not located within a previously
identified QTL, mice deficient in Cidea do show increased metabolic rates and resistance to obesity when
on a high-fat diet [58]. Cidea expression is strongly associated with the production of lipid droplets in white adipose tissue, with increased expression enhancing the size
of the lipid droplets [59]. In addition, this increase is also
associated with increased insulin sensitivity [59]. Cidea
expression is typically regulated by Pparg and our data
show that Cidea and Pparg show similar expression
trends (Figure 3). However, the 3-way interaction of
Pparg was not significant at the whole genome level.
Remaining questions are why such strong differences in
Cidea expression were observed between SM/J males
and SM/J females and whether or not these effects are
also observed in other strains. To our knowledge, there
is no data within the literature addressing sex specific
differences in Cidea expression in relation to diet. Most
studies examining expression levels do not separate out
sex effects, with few exceptions [60], and indeed, for our
data set, the effect observed in SM/J males were strong
enough that when SM/J males and SM/J females were
pooled together a significant increase in Cidea was still
observed. Thus, future studies would benefit from
separating out and examining the sexes individually in
order to determine if significant sex effects are likewise occurring.

Conclusions
These data show that dietary fat intake significantly impacts gene expression levels, particularly in SM/J relative
to LG/J. This is consistent with previous phenotypic data
that has shown SM/J to be more responsive than LG/J
to a high-fat diet for metabolic syndrome associated
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traits, such as obesity, diabetes and lipid serum levels
[23,24]. Many of the genes that are affected by diet are
related to cellular defense, stress, and inflammation, suggesting that increased dietary fat intake promotes processes related to hepatic inflammation more so in SM/J
than in LG/J. As the prevalence of NAFLD and its association with obesity and increased risk for metabolic syndrome steadily increases among Western societies, it is
becoming vital that we understand the factors that contribute to individual variability in and susceptibility to this
disease. Previous work has shown that genetic differences
between SM/J and LG/J contribute to the amount of fat
that accumulates within the liver on a high-fat diet [32]
and QTLs for this trait have been mapped in recombinant
inbred strains produced from these two parent strains. In
accordance with this and our findings that gene expression
profiles in response to high-fat diet produces a strong inflammatory response within the liver, particularly for SM/
J, we suggest that SM/J and its cross with the unresponsive
LG/J strain are a good model for examining non-alcoholic
fatty liver disease and its role in the metabolic syndrome.

Methods
In order to assess the effects of dietary intake on gene expression in SM/J and LG/J mice, males and females from
each strain were placed on either a low-fat diet (15%, Research Diets #D12284) or high-fat (42%, Harlan-Teklad
#TD88137) diet immediately after weaning (3weeks) until
20 weeks of age (Table 5). Previous work has shown that
SM/J mice consume more calories per gram of body mass
than LG/J; however, there is no difference in the amount
of energy consumed per body mass between individuals
fed a high-fat versus a low-fat diet for either strain [24]. At
20 weeks, mice were sacrificed in late morning after a
four-hour fast and tissue was collected from 4 males and 4
females from each strain and diet. The liver tissue was immediately frozen in liquid nitrogen and stored at −80°C
until extraction. All animal procedures were approved by
Table 5 Components of high-fat and low-fat diets

Figure 3 Comparison of Cidea and Pparg intensity values.
Abbrev: LF-F: Low-fat female; LF-M: Low-fat male; HF-F: High-fat
female; HF-M: High-fat male. Transformed data are used for
comparison purposes. Error bars represent standard error of
the mean.

High fat diet

Low fat diet

Energy from fat (%)

42

15

Casein (g/kg)

195

197

Sugars (g/kg)

341

307

Corn starch (g/kg)

150

313

Cellulose (g/kg)

50

50

Corn oil (g/kg)

0

58

Hydrogenated coconut oil (g/kg)

0

7

Anhydrous milk fat (g/kg)

210

0

Cholesterol (g/kg)

1.5

0

Kilojoules per gram

18.95

16.99
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the Washington University in St. Louis Institutional Animal Care and Use Committee (IACUC).
Total RNA was extracted using RNeasy® 96 Universal
Tissue extraction kits (Qiagen, Valencia, CA) and quantified
using a Nanodrop™ 2000 (Thermo Scientific, Wilmington,
DE). RNA samples were submitted to the Washington University Microarray Core Facility, where quality was assessed using a 2100 Bioanalyzer (Agilent Tecnologies, Palo
Alto, CA). RNA was reverse transcribed and amplified
using an Illumina TotalPrep amplification kit (Ambion,
Austin, TX) and then hybridized onto Illumina® WG-6 v.2
BeadChips (Illumina, San Diego, CA). Arrays were scanned
using the Illumina Beadstation 500. Images were processed
using Illumina BeadScan software and intensity values were
analyzed using Illumina BeadStudio.
Illumina raw data from 45,281 unique probes were read
into R statistical software using the Lumi package [61].
Data were transformed using a variance stabilization
transformation [62], which takes into account the large
number of technical replicates on Illumina arrays, and
normalized using a robust spline normalization. Genes
that showed no significant expression were filtered from
the data set prior to analysis, leaving 26,209 transcripts analyzed for the liver. The data was then read into Partek
Genomics software v. 6.5 (Partek Incorporated, St. Louis,
MO) for further statistical analysis. An ANOVA was used
to examine the impact of diet, strain, sex, and their interactions (diet x strain, diet x sex, sex x strain, and diet x sex
x strain) on differential gene expression. A genome-wide
false discovery rate threshold of 0.05 was used to determine statistical significance.
K-means and hierarchical clustering analysis were performed in Partek (Partek Incorporated, St. Louis, MO)
on genes that showed significant diet-by-strain interactions (FDR<0.05). K-means clustering was preformed
using a Euclidian distance function with 1,000 iterations
utilizing different values of K. The number of clusters
with the lowest David-Bouldin value was identified as
the most likely value of K. Hierarchical clustering was
performed on group mean data using a Euclidian distance function and average linkage method.
The Gene Ontology (GO) database PANTHER (http://
pantherdb.org) was used to determine biological processes
and biochemical pathways that were enriched with differentially expressed genes. Pathways and processes with
p values<0.05 were considered to be significant.
In order to determine if previously identified QTLs for
diabetes, serum lipid levels, and obesity were significantly enriched with genes exhibiting a significant dietby-strain interaction, a chi-square test was used to determine if the number of these genes located within QTLs
significantly differed from what would be expected by
chance. Probability values of <0.05 were used to determine significance.
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